Skip to main content
Log in

The GREES Recommendations for the Registration of New Drugs in the Prevention and Treatment of Osteoporosis

  • Letter to the Editor
  • Published:
Calcified Tissue International Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Reginster JY, on behalf of the Group for the Respect of Ethics and Excellence in Science (GREES) (1995) Recommendations for the registration of new chemical entities used in the prevention and treatment of osteoporosis. Calcif Tissue Int 57:247–250

    Article  CAS  PubMed  Google Scholar 

  2. Anonymous (1993) Consensus development conference: diagnosis, prophylaxis, and treatment of osteoporosis. Am J Med 94:646–650

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kanis, J., Delmas, P., Meunier, P. et al. The GREES Recommendations for the Registration of New Drugs in the Prevention and Treatment of Osteoporosis. Calcif Tissue Int 59, 410–411 (1996). https://doi.org/10.1007/s002239900149

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s002239900149

Keywords

Navigation